Results of up-front surgery combined with adjuvant chemotherapy for pancreatic head cancer: Adjuvant gemcitabine chemotherapy may be more effective for borderline resectable cases.

Taku Aoki,Takeyuki Watadani,Hiroyuki Akai,Yoshihiro Sakamoto,Yasuhiko Sugawara,Kiyoshi Hasegawa,Norihiro Kokudo

doi:10.1016/j.pan.2014.05.751

Results of up-front surgery combined with adjuvant chemotherapy for pancreatic head cancer: Adjuvant gemcitabine chemotherapy may be more effective for borderline resectable cases.

Taku Aoki, Takeyuki Watadani + Show 5 more

https://doi.org/10.1016/j.pan.2014.05.751

Copy DOI

Journal: Pancreatology

Publication Date: Jun 1, 2014

Affiliation: The University of Tokyo

#Adjuvant Gemcitabine Chemotherapy #Pancreatic Cancer Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

s / Pancreatology 14 (2014) S1eS129 S110 Conclusion: Clear trend in PFS increase in pancreatic cancer patients with low grade hENT1 expression treated with TG in adjuvant setting was revealed. Large-scale study is needed to prove our results and hypothesis.

Full Text